| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |